1. Cell Biology
  2. Immunology and Inflammation

Robust T cell activation requires an eIF3-driven burst in T cell receptor translation

  1. Dasmanthie DeSilva
  2. Lucas Ferguson
  3. Grant H Chin
  4. Benjamin E Smith
  5. Ryan A Apathy
  6. Theodore L Roth
  7. Franziska Blaeschke
  8. Marek Kudla
  9. Alexander Marson
  10. Nicholas T Ingolia
  11. Jamie HD Cate  Is a corresponding author
  1. University of California, Berkeley, United States
  2. University of California, San Francisco, United States
  3. Gladstone-UCSF Institute of Genomic Immunology, United States
https://doi.org/10.7554/eLife.74272
Share this article
Cite this article
  1. Dasmanthie DeSilva
  2. Lucas Ferguson
  3. Grant H Chin
  4. Benjamin E Smith
  5. Ryan A Apathy
  6. Theodore L Roth
  7. Franziska Blaeschke
  8. Marek Kudla
  9. Alexander Marson
  10. Nicholas T Ingolia
  11. Jamie HD Cate
(2021)
Robust T cell activation requires an eIF3-driven burst in T cell receptor translation
eLife 10:e74272.
https://doi.org/10.7554/eLife.74272
  2. Download BibTeX
  3. Download .RIS

Abstract

Activation of T cells requires a rapid surge in cellular protein synthesis. However, the role of translation initiation in the early induction of specific genes remains unclear. Here we show human translation initiation factor eIF3 interacts with select immune system related mRNAs including those encoding the T cell receptor (TCR) subunits TCRA and TCRB. Binding of eIF3 to the TCRA and TCRB mRNA 3'-untranslated regions (3'-UTRs) depends on CD28 coreceptor signaling and regulates a burst in TCR translation required for robust T cell activation. Use of the TCRA or TCRB 3'-UTRs to control expression of an anti-CD19 chimeric antigen receptor (CAR) improves the ability of CAR-T cells to kill tumor cells in vitro. These results identify a new mechanism of eIF3-mediated translation control that can aid T cell engineering for immunotherapy applications.

Data availability

Sequencing data has been deposited in GEO (GSE191306).Code used to analyze the microscopy images is available on github at https://github.com/Llamero/TCR_colocalization_analysis-macro

The following data sets were generated

Article and author information

Author details

  1. Dasmanthie DeSilva

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    Dasmanthie DeSilva, A provisional patent application has been filed on some of the work presented herein..

  2. Lucas Ferguson

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.

  3. Grant H Chin

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.

  4. Benjamin E Smith

    School of Optometry, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.

  5. Ryan A Apathy

    Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.

  6. Theodore L Roth

    Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, United States
    Competing interests
    Theodore L Roth, is a co-founder of Arsenal Therapeutics..

  7. Franziska Blaeschke

    Gladstone-UCSF Institute of Genomic Immunology, San Francisco, United States
    Competing interests
    No competing interests declared.

  8. Marek Kudla

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.

  9. Alexander Marson

    Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, United States
    Competing interests
    Alexander Marson, is a compensated co-founder, member of the boards of directors, and a member of the scientific advisory boards of Spotlight Therapeutics and Arsenal Biosciences. Was a compensated member of the scientific advisory board at PACT Pharma and was a compensated advisor to Juno Therapeutics. Owns stock in Arsenal Biosciences, Spotlight Therapeutics, PACT Pharma and Merck. A.M. has received fees from Vertex, Merck, Amgen, Trizell, Genentech, AlphaSights, Rupert Case Management and Bernstein. Is an investor in and informal advisor to Offline Ventures. The Marson lab has received research support from Juno Therapeutics, Epinomics, Sanofi, GlaxoSmithKline, Gilead, and Anthem..

  10. Nicholas T Ingolia

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3395-1545

  11. Jamie HD Cate

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    For correspondence
    j-h-doudna-cate@berkeley.edu
    Competing interests
    Jamie HD Cate, A provisional patent application has been filed on some of the work presented herein..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5965-7902

Funding

National Institutes of Health (R01-GM065050)

  • Dasmanthie DeSilva
  • Grant H Chin
  • Jamie HD Cate

Cancer Research Institute (N/A)

  • Alexander Marson

Chan Zuckerberg Initiative (N/A)

  • Ryan A Apathy
  • Theodore L Roth
  • Alexander Marson

Innovative Genomics Institute (N/A)

  • Ryan A Apathy
  • Theodore L Roth
  • Alexander Marson

Parker Institute for Cancer Immunotherapy (N/A)

  • Alexander Marson

Tang Prize for Biopharmaceutical Science (N/A)

  • Jamie HD Cate

Damon Runyon Cancer Research Foundation (DRR#37-15)

  • Nicholas T Ingolia

National Institutes of Health (DP2 CA195768)

  • Lucas Ferguson
  • Marek Kudla
  • Nicholas T Ingolia

National Institutes of Health (P30EY003176)

  • Benjamin E Smith

National Institutes of Health (S10 OD018174)

  • Dasmanthie DeSilva

Care-for-Rare Foundation (N/A)

  • Franziska Blaeschke

German Research Foundation (N/A)

  • Franziska Blaeschke

Burroughs Wellcome Fund (N/A)

  • Alexander Marson

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2021, DeSilva et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,140
    views
  • 568
    downloads
  • 20
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Dasmanthie DeSilva
  2. Lucas Ferguson
  3. Grant H Chin
  4. Benjamin E Smith
  5. Ryan A Apathy
  6. Theodore L Roth
  7. Franziska Blaeschke
  8. Marek Kudla
  9. Alexander Marson
  10. Nicholas T Ingolia
  11. Jamie HD Cate
(2021)
Robust T cell activation requires an eIF3-driven burst in T cell receptor translation
eLife 10:e74272.
https://doi.org/10.7554/eLife.74272

Share this article

https://doi.org/10.7554/eLife.74272

Categories and tags

Research organism

Further reading

    1. Cell Biology

    Spatiotemporal recruitment of the ubiquitin-specific protease USP8 directs endosome maturation

    Yue Miao, Yongtao Du ... Mei Ding
    Research Article

    The spatiotemporal transition of small GTPase Rab5 to Rab7 is crucial for early-to-late endosome maturation, yet the precise mechanism governing Rab5-to-Rab7 switching remains elusive. USP8, a ubiquitin-specific protease, plays a prominent role in the endosomal sorting of a wide range of transmembrane receptors and is a promising target in cancer therapy. Here, we identified that USP8 is recruited to Rab5-positive carriers by Rabex5, a guanine nucleotide exchange factor (GEF) for Rab5. The recruitment of USP8 dissociates Rabex5 from early endosomes (EEs) and meanwhile promotes the recruitment of the Rab7 GEF SAND-1/Mon1. In USP8-deficient cells, the level of active Rab5 is increased, while the Rab7 signal is decreased. As a result, enlarged EEs with abundant intraluminal vesicles accumulate and digestive lysosomes are rudimentary. Together, our results reveal an important and unexpected role of a deubiquitinating enzyme in endosome maturation.

    1. Cancer Biology
    2. Cell Biology

    Automated workflow for the cell cycle analysis of (non-)adherent cells using a machine learning approach

    Kourosh Hayatigolkhatmi, Chiara Soriani ... Simona Rodighiero
    Tools and Resources

    Understanding the cell cycle at the single-cell level is crucial for cellular biology and cancer research. While current methods using fluorescent markers have improved the study of adherent cells, non-adherent cells remain challenging. In this study, we addressed this gap by combining a specialized surface to enhance cell attachment, the FUCCI(CA)2 sensor, an automated image analysis pipeline, and a custom machine learning algorithm. This approach enabled precise measurement of cell cycle phase durations in non-adherent cells. This method was validated in acute myeloid leukemia cell lines NB4 and Kasumi-1, which have unique cell cycle characteristics, and we tested the impact of cell cycle-modulating drugs on NB4 cells. Our cell cycle analysis system, which is also compatible with adherent cells, is fully automated and freely available, providing detailed insights from hundreds of cells under various conditions. This report presents a valuable tool for advancing cancer research and drug development by enabling comprehensive, automated cell cycle analysis in both adherent and non-adherent cells.

    1. Cell Biology

    Spatial and temporal coordination of Duox/TrpA1/Dh31 and IMD pathways is required for the efficient elimination of pathogenic bacteria in the intestine of Drosophila larvae

    Fatima Tleiss, Martina Montanari ... C Leopold Kurz
    Research Article

    Multiple gut antimicrobial mechanisms are coordinated in space and time to efficiently fight foodborne pathogens. In Drosophila melanogaster, production of reactive oxygen species (ROS) and antimicrobial peptides (AMPs) together with intestinal cell renewal play a key role in eliminating gut microbes. A complementary mechanism would be to isolate and treat pathogenic bacteria while allowing colonization by commensals. Using real-time imaging to follow the fate of ingested bacteria, we demonstrate that while commensal Lactiplantibacillus plantarum freely circulate within the intestinal lumen, pathogenic strains such as Erwinia carotovora or Bacillus thuringiensis, are blocked in the anterior midgut where they are rapidly eliminated by antimicrobial peptides. This sequestration of pathogenic bacteria in the anterior midgut requires the Duox enzyme in enterocytes, and both TrpA1 and Dh31 in enteroendocrine cells. Supplementing larval food with hCGRP, the human homolog of Dh31, is sufficient to block the bacteria, suggesting the existence of a conserved mechanism. While the immune deficiency (IMD) pathway is essential for eliminating the trapped bacteria, it is dispensable for the blockage. Genetic manipulations impairing bacterial compartmentalization result in abnormal colonization of posterior midgut regions by pathogenic bacteria. Despite a functional IMD pathway, this ectopic colonization leads to bacterial proliferation and larval death, demonstrating the critical role of bacteria anterior sequestration in larval defense. Our study reveals a temporal orchestration during which pathogenic bacteria, but not innocuous, are confined in the anterior part of the midgut in which they are eliminated in an IMD-pathway-dependent manner.